Comments
Loading...

MiNK Therapeutics

INKTNASDAQ
Logo brought to you by Benzinga Data
$0.690050
-0.01-2.11%
At close: -
$0.704000
0.012.02%
After Hours: 5:42 PM EDT

MiNK Therapeutics (NASDAQ:INKT) Stock, Earnings Estimates, EPS, And Revenue

MiNK Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date
Nov 14
EPS
$-0.050
Quarterly Revenue
$0K
Annual Revenue
(as of Sep 30)

Analyze the earnings history of MiNK Therapeutics using advanced sorting and filters.

Data brought to you by Benzinga APIs

MiNK Therapeutics (INKT) Earnings Per Share

Quarterly Earnings Surprise Amount

Fiscal Quarter EndDate ReportedActual EPSEstimated EPSSurprise %
Sep 20242024-11-14$-0.05$-0.0837.5 %
Jun 20242024-08-13$-0.07$-0.1030.0 %
Mar 20242024-05-14$-0.11$-0.1526.7 %
Dec 20232024-03-21$-0.16$-0.15-6.67 %

MiNK Therapeutics (INKT) Revenue

Quarterly Revenue Surprise Amount

Fiscal Quarter EndDate ReportedActual RevenueEstimated RevenueSurprise %

FAQ

Q

When is MiNK Therapeutics (NASDAQ:INKT) reporting earnings?

A

MiNK Therapeutics ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 14, 2024 for Q3.

Q

What were the latest earnings per share (EPS) for MiNK Therapeutics (NASDAQ:INKT)?

A

MiNK Therapeutics ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 14, 2024 for Q3 and the Actual EPS was $-0.05, which beat the estimate of $-0.08.

Q

What were MiNK Therapeutics’s (NASDAQ:INKT) revenues?

A

MiNK Therapeutics ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 14, 2024 for Q3 and the Actual EPS was {{actualEPS}}, which hit the estimate of {{estEPS}}.

Browse earnings estimates, EPS, and revenue on all stocks.

People Also Watch